sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
14-Feb-2016 01:08
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 26-50 out of 1159.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>

Public Release: 1-Feb-2016
Annals of Internal Medicine
Advice for preventing spread of Zika; news from Annals of Internal Medicine
In an article published in Annals of Internal Medicine, experts offer advice for preventing the spread of Zika virus in the West.

Contact: Cara Graeff
American College of Physicians

Public Release: 28-Jan-2016
Case Western faculty receive funding for new technologies aimed at blood, lung disorders
Three Case Western Reserve University faculty members have received funding to further develop emerging technologies aimed at malaria, cystic fibrosis, and sickle cell anemia.
National Center for Accelerated Innovation

Contact: Marc Kaplan
Case Western Reserve University

Public Release: 28-Jan-2016
BMC Infectious Diseases
Vaccine study shapes plan to wipe out rabies in free-roaming dogs
Rabies could be eradicated from street dogs in India with the help of a new smartphone app, a study led by Mission Rabies and the University of Edinburgh's Royal (Dick) School of Veterinary Studies has shown.

Contact: Jen Middleton
University of Edinburgh

Public Release: 28-Jan-2016
Chemists uncover how key agent allows diseases to reproduce
University of Iowa chemists have revealed the chemistry behind how certain diseases, from anthrax to tuberculosis, replicate. The key lies in the function of a gene absent in humans, called thyX, and its ability to catalyze the DNA building block thymine. The finding could help drug companies target the chemical reaction, rather than testing millions of compounds, to stop these diseases. Results published in the journal Science.
National Institutes of Health

Contact: Richard Lewis
University of Iowa

Public Release: 28-Jan-2016
Lancet Infectious Diseases
Resistance to key HIV drug 'concerningly common'
HIV drug resistance to tenofovir, an antiretroviral drug vital to most modern HIV treatment and prevention strategies, is surprisingly and worryingly common according to a large study led by UCL and funded by the Wellcome Trust. The research, co-authored by researchers at Stanford University and the London School of Hygiene and Tropical Medicine and published in the Lancet Infectious Diseases journal, studied 1,926 HIV patients across the world with uncontrolled HIV despite being prescribed antiretrovirals.
Wellcome Trust

Contact: Harry Dayantis
University College London

Public Release: 27-Jan-2016
Biology Letters
New way to detect human-animal diseases tested in lemurs
RNA sequencing is uncovering emerging diseases in wildlife that other diagnostic tests cannot detect. Researchers used a technique called transcriptome sequencing to screen for blood-borne diseases in Madagascar's lemurs, distant primate cousins to humans. The animals were found to be carrying several previously unknown parasites similar to those that cause Lyme disease in humans. The approach could pave the way for earlier, more accurate detection of disease outbreaks that move between animals and people.
Ambatovy Minerals S.A., Duke Lemur Center

Contact: Robin Ann Smith
Duke University

Public Release: 27-Jan-2016
Six mental health care projects in developing countries demonstrate effective, affordable options
Six innovative projects in Africa, Asia and Haiti, funded by the Canadian Government through Grand Challenges Canada, have pioneered ways of providing effective, affordable mental health care rarely available in low-resource developing countries.

Contact: Terry Collins
Grand Challenges Canada

Public Release: 26-Jan-2016
Emerging Infectious Diseases
UW-Madison researchers find Zika virus in Colombia, look for ways to stop it
In October 2015, a team of researchers at the University of Wisconsin-Madison and Universidad de Sucre in Colombia ran the first tests confirming the presence of Zika virus transmission in the South American country. In a study published today, the team documents a disease trajectory that started with nine positive patients and has now spread to more than 13,000 infected individuals in that country.

Contact: Matthew Aliota
University of Wisconsin-Madison

Public Release: 26-Jan-2016
Scientists prove key aspect of evolutionary theory
Evolutionary theory predicts that pairs of chromosomes within asexual organisms will evolve independently of each other and become increasingly different over time in a phenomenon called the 'Meselson effect.' Researchers from the University of Glasgow have demonstrated the Meselson effect for the first time in any organism at a genome-wide level, studying a parasite called Trypanosoma brucei gambiense.
Wellcome Trust

Contact: Emily Packer

Public Release: 25-Jan-2016
Experts debate benefits and challenges of new ATA guidelines & differentiated thyroid cancer
In a stimulating new Roundtable Discussion, a distinguished panel of leading physicians and clinical researchers highlight the key changes, new topics, and areas of ongoing controversy in the "2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer." The Roundtable Discussion (http://register.liebertpub.com/thyroidroundtable/) and the ATA's 2015 Management Guidelines (http://online.liebertpub.com/doi/full/10.1089/thy.2015.0020) are available free to download on the website of Thyroid.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 25-Jan-2016
American Journal of Respiratory and Critical Care Medicine
Most commonly used TB test fails to accurately diagnose pregnant HIV positive women
New research finds that the most commonly used test for tuberculosis fails to accurately diagnose TB in up to 50 percent of pregnant women who are HIV positive. The research published early online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine is believed to be the first study to compare the accuracy of two TB tests -- the Quantiferon Gold In Tube blood test and the more commonly used TST or tuberculin skin test -- in this population.
NIH/National Institute of Allergy and Infectious Diseases, National Institutes of Health, Gilead Foundation, Ujala Foundation, Weill Cornell Clinical and Translational Science Center

Contact: Dacia Morris
American Thoracic Society

Public Release: 25-Jan-2016
Researchers may hold key to developing a single treatment against several types of Ebola
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola. The study is currently available in Cell.
NIH/National Institute of Allergy and Infectious Diseases of the National Institutes of Health, Defense Threat Reduction Agency

Contact: Donna Ramirez
University of Texas Medical Branch at Galveston

Public Release: 25-Jan-2016
Funding received to develop device to help save the lives of new mothers worldwide
Professor of International Maternal Health Andrew Weeks from the Institute of Translational medicine has been awarded £850,000 to further develop an award-winning device that could save the lives of women all over the world.
National Institute of Health Research

Contact: Simon Wood
University of Liverpool

Public Release: 21-Jan-2016
Antibodies may provide 'silver bullet' for Ebola viruses
Researchers at Vanderbilt University Medical Center and the University of Texas Medical Branch in Galveston (UTMB) reported today in the journal Cell that they have isolated human monoclonal antibodies from Ebola survivors which can neutralize multiple species of the virus.
NIH/National Institute of Allergy and Infectious Diseases, Defense Threat Reduction Agency award

Contact: Craig Boerner
Vanderbilt University Medical Center

Public Release: 21-Jan-2016
Should India's quacks be trained to deliver basic patient care?
Should unqualified practitioners be trained to deliver basic patient care to alleviate India's doctor shortage, asks a special report published by The BMJ today?

Contact: Emma Dickinson

Public Release: 21-Jan-2016
PLOS Pathogens
Immune response differences might determine severity of West Nile Virus disease
While most West Nile Virus infections in humans are asymptomatic and go unnoticed, the virus causes serious and sometimes fatal neurologic illness in some people. A study published on Jan. 21 in PLOS Pathogens suggests that an exaggerated and abnormal immune response contributes to the development of neurologic symptoms following West Nile Virus infection.

Contact: Eddie James

Public Release: 20-Jan-2016
CSU's BioMARC helps advance vaccines for Department of Defense
Colorado State University's Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC) has been awarded a 10-month, $4.6 million contract funded by the Department of Defense (DoD) to help develop and manufacture new vaccines to fight encephalitic viruses that cause inflammation of the brain.
Department of Defense

Contact: Jeff Dodge
Colorado State University

Public Release: 19-Jan-2016
Biochemical and Biophysical Research Communications
Infant-friendly flu vaccine developed with key protein
According to the World Health Organization, influenza causes serious illness among millions of people each year, resulting in 250,000 to 500,000 deaths. Those most at risk include infants younger than six months, because they cannot be vaccinated against the disease. Now, researchers at the University of Missouri School of Medicine have identified a naturally occurring protein that, when added to the flu vaccine, may offer protection to babies during their first months of life.
National Institutes of Health, University of Missouri Research Board, Leda J. Sears Trust

Contact: Jeff Hoelscher
University of Missouri-Columbia

Public Release: 19-Jan-2016
European Respiratory Journal
Women at higher risk to develop chronic obstructive pulmonary disease
Researchers from Lund University Sweden have through a new diagnostic method been able to show that the risk of developing chronic obstructive pulmonary disease could be twice as high for women as it is for men. This means that being a woman may be an independent risk factor for developing this disease.

Contact: Cecilia Schubert
Lund University

Public Release: 19-Jan-2016
Text messages can help reduce blood pressure
Study shows text message reminders help people stick to their prescribed treatment with improved blood pressure as a result.

Contact: Tom Calver
University of Oxford

Public Release: 19-Jan-2016
Journal of Infectious Diseases
Immunity genes could protect some from E. coli while others fall ill
When a child comes home from preschool with a stomach bug that threatens to sideline the whole family for days, why do some members of the family get sick while others are unscathed? According to a Duke Health study published Jan. 19, 2016 in the Journal of Infectious Diseases, a person's resistance to certain germs, specifically E. coli bacteria, could come down to their very DNA.
United States Advanced Research Projects Agency, Program for Appropriate Technology

Contact: Samiha Khanna
Duke University Medical Center

Public Release: 18-Jan-2016
Proceedings of the National Academy of Sciences
Scientists take steps to make weak TB drugs strong again
Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings, based on mapping the detailed three-dimensional structure of the drugs interacting with an essential enzyme in the TB germ, also reveal why some TB drugs are more potent than others and suggest how drug developers can make fluoroquinolones more efficacious against mutations that make the lung disease drug resistant.
European Molecular Biology Organization, US Department of Veterans Affairs, NIH/National Institute of Allergy and Infectious Diseases, NIH/National Cancer Institute, NIH/National Institute of General Medical Sciences, and others

Contact: Catherine Gara
Johns Hopkins Medicine

Public Release: 18-Jan-2016
The Lancet
Slow progress on stillbirth prevention: Parents of 2.6 million babies suffer in silence each year
More than 2.6 million stillbirths continue to occur globally every year with very slow progress made to tackle this 'silent problem,' according to a major new series of research on ending preventable stillbirths.

Contact: Jenny Orton
London School of Hygiene & Tropical Medicine

Public Release: 17-Jan-2016
Increased childbirth at Indian health facilities led to no matching reduction in maternal death
To reduce maternal and neo-natal deaths, India launched a cash transfer program in 2005 that provides monetary incentives for women to give birth in health facilities instead of at home. While the program successfully increased the use of health facilities for child birth, it did not reduce maternal deaths as much, especially in poor areas. This is according to a doctoral dissertation published at Umeå University.

Contact: Daniel Harju
Umea University

Public Release: 15-Jan-2016
UGA researchers discover how trypanosome parasites communicate with each other
While scientists have known for years that African trypanosomes cause sleeping sickness, they've been left scratching their heads as to how these tiny single-celled organisms communicate. A University of Georgia study, published Jan. 14 in the journal Cell, helps solve this mystery. The UGA researchers discovered that long filaments--that look like beads on a string -- form by budding from the flagellum of African trypanosomes and then release pieces of the parasite into the host.
National Institutes of Health

Contact: Stephanie Schupska
University of Georgia

Showing releases 26-50 out of 1159.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>